Interesting argument, although the biggest obstacle is the rareness of the syndrome, the biomarker deficiencies most strongly make early warning almost impossible. Only fALS patients seem to know 'fast:' in most cases because they are very familiar with the disorder.

The best efficacy claims are related to the pacer but the intervention timing is fairly critical for getting near maximum benefit.